Publications by authors named "James M McCarty"

Claim this Profile
S
Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled study.
Melinda J Hamer, James M McCarty, Benjamin C Pierson, Jason A Regules, Jason Mendy

Lancet Microbe· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chikungunya virus virus-like particle vaccine is well tolerated and immunogenic in chikungunya seropositive individuals.
James M McCarty, Lisa Bedell, Jason Mendy, Emily E Coates, Grace L Chen

Vaccine· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central Nervous System Coccidioidomycosis in Children: A Retrospective Case Series.
Fouzia Naeem, Fred Laningham, Linda Giglio, Julia Sharma, Patricia Quebada Clerkin, James M McCarty

Pediatr Infect Dis J· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of partial doses of live oral cholera vaccine CVD 103-HgR in children in the United States.
James M McCarty, David Cassie, Lisa Bedell

Vaccine· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial.
Sean R Bennett, James M McCarty, Roshan Ramanathan, Jason Mendy, Jason S Richardson

Lancet Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neonatal Coccidioidomycosis: A Single-center Experience and Review of the Literature.
Jessica Vaughn, Mary Anne Tablizo, Zahia Zayed, Robert R Hepple, James M McCarty

Pediatr Infect Dis J· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Adolescents Aged 12-17 Years in the United States.
James M McCarty, David Cassie, Lisa Bedell, Michael D Lock, Sean Bennett

Am J Trop Med Hyg· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrocephalus in Mexican children with Coccidioidal Meningitis: Clinical, serological, and neuroimaging findings.
María F De la Cerda-Vargas, B A Sandoval-Bonilla, James M McCarty, Fernando Chico-Ponce De León, José A Candelas-Rangel

Surg Neurol Int· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children Aged 2-5 Years in the United States.
James M McCarty, David Cassie, Lisa Bedell, Michael D Lock, Sean Bennett

Am J Trop Med Hyg· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children and Adolescents Aged 6-17 Years.
James M McCarty, Emma C Gierman, Lisa Bedell, Michael D Lock, Sean Bennett

Am J Trop Med Hyg· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial.
James M McCarty, Michael D Lock, Sean Bennett, Kristin M Hunt, Jakub K Simon

Vaccine· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric Coccidioidomycosis: Case Series From a California Pediatric Infectious Diseases Clinic.
Lauren A Lee, Gail L Sondermeyer Cooksey, Janice J Kim, Amandeep Kahal, Debra Gilliss, James M McCarty

Pediatr Infect Dis J· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18-45.
James M McCarty, Michael D Lock, Kristin M Hunt, Jakub K Simon, Marc Gurwith

Vaccine· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of Pediatric Coccidioidomycosis in California, 2000-2012.
Gail L Sondermeyer, Lauren A Lee, Debra Gilliss, James M McCarty, Duc J Vugia

Pediatr Infect Dis J· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series.
Emily R Levy, James M McCarty, Andi L Shane, Peggy S Weintrub

Clin Infect Dis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric coccidioidomycosis in central California: a retrospective case series.
James M McCarty, Lindsey C Demetral, Lukasz Dabrowski, Amandeep K Kahal, Anna M Bowser

Clin Infect Dis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of azithromycin and cefadroxil for the treatment of uncomplicated skin and skin structure infections.
Maureen B Jennings, James M McCarty, Neil M Scheffler, Anthony D Puopolo, Constance D Rothermel

Cutis· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis